Companies /Healthcare

Agilent Technologies Inc

NYSE: A Diagnostics & Research
$157.86
â–² $2.78 (+1.79%) today
Markets open · 12:35pm ET

Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
83%
EPS beat rate
+3.06%
Avg. EPS surprise
Consecutive EPS beats
A vs Market · 30-day return after each reportAS&P 500
−12%−6%0%+6%+6.3%+4.7%Q2 25+2.7%+2.7%Q3 25−12.3%+1.9%Q4 25−7.4%−8.3%Q1 26−1.9%−1.0%Q2 26
−12%−6%0%+6%Q2 25Q3 25Q4 25Q1 26Q2 26
A EPS Trend · estimate vs actualEstimateActual
$0.00$0.50$1.00$1.50$1.26$1.31Q2 25$1.37$1.37Q3 25$1.58$1.59Q4 25$1.37$1.36Q1 26$1.41$1.49Q2 26$1.49$1.62Q3 26
$0.00$0.50$1.00$1.50Q2 25Q4 25Q2 26
A Revenue Trend · estimate vs actualEstimateActual
$0$600.0M$1.2B$1.8B$1.6B$1.7BQ2 25$1.7B$1.7BQ3 25$1.8B$1.9BQ4 25$1.8B$1.8BQ1 26$1.8B$1.8BQ2 26$1.8B$1.9BQ3 26
$0$600.0M$1.2B$1.8BQ2 25Q4 25Q2 26

Quarter by Quarter

Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Non-GAAP EPS of $1.62 includes a $0.06 net benefit from tariff refunds ($17 million pre-tax). Non-GAAP adjustments exclude $15M restructuring costs, $21M intangible amortization, $37M transformational initiatives, $7M acquisition and integration costs, $5M net loss on equity securities, $8M other, and $4M tax adjustment. $1.62 est. $1.49 +9.01% $1.9B est. $1.8B +1.98%
Q2 2026 $1.49 est. $1.41 +5.80% $1.8B est. $1.8B +2.03%
Q1 2026 $1.36 est. $1.37 −0.61% $1.8B est. $1.8B −0.55%
Q4 2025 $1.59 est. $1.58 +0.37% $1.9B est. $1.8B +1.56%
Q3 2025 $1.37 est. $1.37 +0.17% $1.7B est. $1.7B +4.32%
Q2 2025 $1.31 est. $1.26 +3.61% $1.7B est. $1.6B +2.56%

Figures from SEC filings and company reports. Not investment advice.